Three-dimensional cultures of prostatic cells: Tissue models for the development of novel anti-cancer therapies

Pharmaceutical Research

Volumn 16, Issue 4, 1999, Pages 486-493

  O'Connor, Kim C ^a  

^a Tulane University   (United States)

Author keywords

Drug therapy; Gel culture; Gene therapy; Prostate cancer; Spheroid

Indexed keywords

CYTOTOXIN; TUMOR VACCINE;

ANTINEOPLASTIC ACTIVITY; CANCER THERAPY; CARCINOGENESIS; CELL CULTURE; CELL FUNCTION; CELL LINE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TRANSGENE; TUMOR GROWTH;

ANIMALS; CELL CULTURE TECHNIQUES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR;

EID: 0032901790     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011906709680     Document Type: Review

References (60)

1. 1. S. H. Landis, T. Murray, S. Bolden, and P. A. Wingo. Cancer statistics, 1998. CA Cancer J. Clin. 48:6-29 (1998).
2. 2. J. L. Mohler, A. W. Partin, J. I. Epstein, R. L. Becker, U. V. Mikel, I. A. Sesterhenn, F. K. Mostofi, D. F. Gleason, Y. Sharief, and D. S. Coffey. Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer 69:511-519 (1992).
3. 3. W. B. Isaacs, G. S. Bova, R. A. Morton, M. J. G. Bussemakers, J. D. Brooks, and C. M. Ewing. Molecular biology of prostate cancer. Semin. Oncol. 21:514-521 (1994).
4. 4. L. W. K. Chung, W. Li, M. E. Gleave, J.-T. Hsieh, H.-C. Wu, R. A. Sikes, H. E. Zhau, M. G. Bandyk, C. J. Logothetis, J. S. Rubin, and A. C. von Eschenbach. Human prostate cancer model: roles of growth factors and extracellular matrices. J. Cell. Biochem. (Suppl) 16H:99-105 (1992).
5. 5. F. Labrie, A. Bélanger, A. Dupont, V. Luu-The, J. Simard, and C. Labrie. Science behind total androgen blockade: from gene to combination therapy. Clin. Invest. Med. 16:475-492 (1993).
6. 6. W. Kreis. Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer. Cancer Invest. 13:296-312 (1995).
7. 7. M. C. Bosland. Animal models for the study of prostate carcinogenesis. J. Cell. Biochem. (Suppl) 16H:89-98 (1992).
8. 8. G. F. Spaulding, J. M. Jessup, and T. J. Goodwin. Advances in cellular construction. J. Cell. Biochem. 51:249-251 (1993).
9. 9. H. Kawamura and I. Ichihara. Primary culture of epithelial cells derived from the rat ventral prostate: formation of three-dimensional acinus-like structure in collagen gel. Prostate 10:153-161 (1987).
10. 10. J. T. Donaldson, J. A. Tucker, T. E. Keane, P. J. Walther, and K. S. Webb. Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid. Int. J. Cancer 46:238-244 (1990).
11. 11. J. Breul, G. Jakse, and R. Hartung. Biomodulation of 5-Fu cytotoxicity by folinic acid and its stereoisomers: in vitro experiments with different cell lines of prostatic cancer. Urol. Res. 23:163-167 (1995).
12. 12. M. Essand, S. Nilsson, and J. Carlsson. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine. Anticancer Res. 13:1261-1268 (1993).
13. 13. S. Clejan, K. C. O'Connor, N. Cowger, M. K. Cheles, S. Haque, and A. C. Primavera. Effects of simulated microgravity on DU 145 human prostate carcinoma cells. Biotechnol. Bioeng. 50:587-597 (1996).
14. 14. D. R. Rowley. Characterization of a fetal urogenital sinus mesenchymal cell line U4F: secretion of a negative growth regulatory activity. In Vitro Cell. Dev. Biol. 28A:29-38 (1992).
15. 15. R. M. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177-184 (1988).
16. 16. J. M. Yuhas, A. P. Li, A. O. Martinez, and A. J. Ladman. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 37:3639-3643 (1977).
17. 17. M. R. Freeman, D. J. Bagli, C. C. Lamb, P. D. Guthrie, T. Uchida, R. E. Slavin, and L. W. K. Chung. Culture of a prostatic cell line in basement membrane gels results in an enhancement of malignant properties and constitutive alterations in gene expression. J. Cell. Physiol. 158:325-336 (1994).
18. 18. C.-J. Fong, E. R. Sherwood, D. M. Sutkowski, G. M. Abu-Jawdeh, H. Yokoo, K. D. Bauer, J. M. Kozlowski, and C. Lee. Reconstituted basement membrane promotes morphological and functional differentiation of primary human prostatic epithelial cells. Prostate 19:221-235 (1991).
19. 19. J. Bauer, D. Grimm, F. Hofstaedter, and W. Wieland. Techniques for studies on growth characteristics of human prostatic cancer cells. Biotechnol. Prog. 8:494-500 (1992).
20. 20. K. C. O'Connor, R. M. Enmon, R. S. Dotson, A. C. Primavera, and S. Clejan. Characterization of autocrine growth factors, their receptors and extracellular matrix present in three-dimensional cultures of DU 145 human prostate carcinoma cells grown in simulated microgravity. Tissue Eng. 3:161-171 (1997).
21. 21. H. Sauer, H. Diedershagen, J. Hescheler, and M. Wartenberg. Calcium-dependence of hydrogen peroxide-induced c-fos expression and growth stimulation of multicellular prostate tumor spheroids. FEBS Lett. 419:201-205 (1997).
22. 22. J. L. Becker, P. R. Papenhausen, and R. H. Widen. Cytogenetic, morphologic, and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary. In Vitro Cell. Dev. Biol. 33:325-331 (1997).
23. 23. J. M. Jessup, D. Brown, W. Fitzgerald, R. D. Ford, A. Nacham, T. J. Goodwin, and G. Spaulding. Induction of carcinoembryonic antigen expression in a three-dimensional culture system. In Vitro Cell. Dev. Biol. 33:352-357 (1997).
24. 24. M. Ingram, G. B. Techy, R. Saroufeem, O. Yazan, K. S. Narayan, T. J. Goodwin, and G. F. Spaulding. Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell. Dev. Biol. 33:459-466 (1997).
25. 25. T. J. Goodwin, T. L. Prewett, D. A. Wolf, and G. F. Spaulding. Reduced shear stress: a major component in the ability of mammalian tissue to form three-dimensional assemblies in simulated microgravity. J. Cell. Biochem. 51:301-311 (1993).
26. 26. H. E. Zhau, T. J. Goodwin, S. -M. Chang, T. L. Baker, and L. W. K. Chung. Establishment of a three-dimensional human prostate organoid co-culture under microgravity-simulated conditions: evaluation of androgen-induced growth and PSA expression. In Vitro Cell. Dev. Biol. 33:375-380 (1997).
27. 27. L. W. K. Chung, H. E. Zhau, and T. T. Wu. Development of human prostate cancer models for chemoprevention and experimental therapeutics studies. J. Cell. Biochem. (Suppl) 28/29:174-181 (1997).
28. 28. M. Koutsilieris, A. Sourla, G. Pelletier, and C. J. Doillon. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer. J. Bone Miner. Res. 9:1823-1832 (1994).
29. 29. A. Sourla, C. Doillon, and M. Koutsilieris. Three-dimensional type I collagen gel system containing MG-63 osteoblasts-like cells as a model for studying local bone reaction caused by metastatic cancer cells. Anticancer Res. 16:2773-2780 (1996).
30. 30. E. Bell. Strategy for the selection of scaffolds for tissue engineering. Tissue Eng. 1:163-179 (1995).
31. 31. C. -J. Fong, E. R. Sherwood, E. -J. Braun, L. A. Berg, C. Lee, and J. M. Kozlowaki. Regulation of prostatic carcinoma cell proliferation and secretory activity by extracellular matrix and stromal secretions. Prostate 21:121-131 (1992).
32. 32. T. Golombick, D. Dajee, and W. R. Bezwoda. Extracellular matrix interactions 2: extracellular matrix structure is important for growth factor localization and function. In Vitro Cell. Dev. Biol. 31:396-403 (1995).
33. 33. R. Janvier, A. Sourla, M. Koutsilieris, and C. J. Doillon. Stromal fibroblasts are required for PC-3 human prostate cancer cells to produce capillary-like formation of endothelial cells in a three-dimensional co-culture system. Anticancer Res. 17:1551-1558 (1997).
34. 34. L. Cheng, J. Sun, T. G. Pretlow, J. Culp, and N. -S. Yang. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy. J. Natl. Cancer Inst. 88:607-611 (1996).
35. 35. J. Geller, L. R. Sionit, K. Connors, and R. M. Hoffman. Measurement of androgen sensitivity in the human prostate in in vitro three-dimensional histoculture. Prostate 21:269-278 (1992).
36. 36. J. Geller, L. R. Sionit, K. Connors, T. Youngkin, and R. M. Hoffman. Expression of prostate-specific antigen in human prostate specimens in in vitro three-dimensional histoculture. In Vitro Cell. Dev. Biol. 29A:523-524 (1993).
37. 37. M. G. Wientjes, T. G. Pretlow, R. A. Badalament, J. K. Burgers, and J. L.-S. Au. Histocultures of human prostate tissue for pharmacologic evaluation. J. Urol. 153:1299-1302 (1995).
38. 38. G. Olbina, D. Miljkovic, R. M. Hoffman, and J. Geller. New sensitive discovery histoculture model for growth-inhibition studies in prostate cancer and BPH. Prostate 37:126-129 (1998).
39. 39. C. T. Chen, Y. Gan, J. L.-S. Au, and M. G. Wientjes. Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation. Cancer Res. 58:2777-2783 (1998).
40. 40. J. Geller, L. Sionit, C. Partido, L. Li, X. Tan, T. Youngkin, D. Nachtsheim, and R. M. Hoffman. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 34:75-79 (1998).
41. 41. C. T. Chen, J. L.-S. Au, and M. G. Wientjes. Pharmacodynamics of doxorubicin in human prostate tumors. Clin. Cancer Res. 4:277-282 (1998).
42. 42. G. T. Klus, J. Nakamura, J.-S. Li, Y.-Z. Ling, C. Son, J. A. Kemppainen, E. M. Wilson, and A. M. H. Brodie. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis. Cancer Res. 56:4956-4964 (1996).
43. 43. J. Geller, C. Partido, L. Sionit, T. Youngkin, D. Nachtsheim, M. Espanol, Y. Tan, and R. Hoffman. Comparison of androgen-independent growth and androgen-dependent growth in BPH and cancer tissue from the same radical prostatectomies in sponge-gel matrix histoculture. Prostate 31:250-254 (1997).
44. 44. J. Geller, L. R. Sionit, A. Baird, M. Kohls, K. M. Connors, and R. M. Hoffman. In vivo and in vitro effects of androgen on fibroblast growth factor-2 concentration in the human prostate. Prostate 25:206-209 (1994).
45. 45. H. Y. Guo, H. Herrera, A. Groce, and R. M. Hoffman. Expression of biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res. 53:2479-2483 (1993).
46. 46. W. C. Yen, M. G. Wientjes, and J. L.-S. Au. Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics. Pharm. Res. 13:1305-1312 (1996).
47. 47. S. D. Perrapato, H. K. Slocum, R. P. Huben, R. Ghosh, and Y. Rustum. Assessment of human genitourinary tumors and chemo-sensitivity testing in 3-dimensional collagen gel culture. J. Urol. 143:1041-1045 (1990).
48. 48. Y. Gan, J. L.-S. Au, J. Lu, and M. G. Wientjes. Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin E, suramin and thiacetazone in human prostate xenograft tumor histocultures. Pharm. Res. 15:1760-1766 (1998).
49. 49. Y. L. Ma, C. Fujiyama, Z. Masaki, and H. Sugihara. Reconstruction of prostatic acinus-like structure from ventral and dorsolateral prostatic epithelial cells of the rat in three-dimensional collagen gel matrix culture. J. Urol. 157:1025-1031 (1997).
50. 50. T. Turner and H. A. Bern. Growth responses of prostatic epithelial cells from male mice neonatally exposed to diethylstilbestrol in serum-free collagen gel culture. Cancer Lett. 52:209-218 (1990).
51. 51. Y. Kusama, J. Enami, and Y. Kano. Growth and morphogenesis of mouse prostate epithelial cells in collagen gel matrix culture. Cell Biol. Int. Rep. 13:569-575 (1989).
52. 52. T. Turner, H. A. Bern, P. Young, and G. R. Cunha. Serum-free culture of enriched mouse anterior and ventral prostatic epithelial cells in collagen gel. In Vitro Cell. Dev. Biol. 26:722-730 (1990).
53. 53. R. M. Hoffman. The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro. Cancer Metast. Rev. 13:169-173 (1994).
54. 54. R. Umbas, J. A. Schalken, T. W. Aalders, B. S. Carter, H. F. M. Karthaus, H.E. Schaafsma, F.M.J. Debruyne, and W.B. Isaacs. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52:5104-5109 (1992).
55. 55. A. Ben-Ze'ev, S. R. Farmer, and S. Penman. Protein synthesis requires cell-surface contact while nuclear events respond to cell shape in anchorage-dependent fibroblasts. Cell 21:365-372 (1980).
56. 56. B. E. Miller, F. R. Miller, and G. H. Heppner. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res. 45:4200-4205 (1985).
57. 57. C. Erlichman and D. Vidgen. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenographs in immune-deprived mice. Cancer Res. 44:5369-5375 (1984).
58. 58. L. W. K. Chung. The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv. 23:33-42 (1995).
59. 59. R. Royai, P. H. Lange, and R. Vessella. Preclinical models of prostate cancer. Semin. Oncol. 23:35-40 (1996).
60. 60. K. M. Francis, K. C. O'Connor, and G. F. Spaulding. Cultivation of fall armyworm ovary cells in simulated microgravity. In Vitro Cell. Dev. Biol. 33:332-336 (1997).